These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37559813)

  • 21. Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS.
    Bellucci M; Germano F; Grisanti S; Castellano C; Tazza F; Mobilia EM; Visigalli D; Novi G; Massa F; Rossi S; Durando P; Cabona C; Schenone A; Franciotta D; Benedetti L
    Front Immunol; 2022; 13():894872. PubMed ID: 35924236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple cranial neuropathy (a teaching case).
    Toro J; Millán C; Díaz C; Reyes S
    Mult Scler Relat Disord; 2013 Oct; 2(4):395-8. PubMed ID: 25877853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guillain-Barré syndrome following the second dose of COVID AstraZeneca vaccine in a 78-year-old male: a case report from Nepal.
    Acharya B; Kc S; Karki S; Thapa P; Kc P
    Ann Med Surg (Lond); 2023 Mar; 85(3):466-469. PubMed ID: 36923770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two possible etiologies of Guillain-Barré syndrome: mRNA-1273 (Moderna) vaccination and scrub typhus: A case report.
    Hwang BW; Bong JB
    Medicine (Baltimore); 2022 Dec; 101(48):e32140. PubMed ID: 36482517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Clinical Case of COVID-19 Vaccine-Associated Guillain-Barré Syndrome.
    Hilts A; Schreiber A; Singh A
    Am J Case Rep; 2022 Aug; 23():e936896. PubMed ID: 35945825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guillain-Barré Syndrome Induced by Vaccination Against COVID-19: A Systematic Review and Meta-Analysis.
    Ogunjimi OB; Tsalamandris G; Paladini A; Varrassi G; Zis P
    Cureus; 2023 Apr; 15(4):e37578. PubMed ID: 37193456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Case of Pharyngeal-Cervical-Brachial Variant of Guillain-Barré Syndrome With Bilateral Glossopharyngeal Paralysis.
    He N; Kartiko MC; Selim M
    Cureus; 2021 Apr; 13(4):e14551. PubMed ID: 34017665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiating Familial Neuropathies from Guillain-Barré Syndrome.
    Bordini BJ; Monrad P
    Pediatr Clin North Am; 2017 Feb; 64(1):231-252. PubMed ID: 27894447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and nerve conduction features in Guillain-Barré syndrome associated with Zika virus infection in Cúcuta, Colombia.
    Uncini A; González-Bravo DC; Acosta-Ampudia YY; Ojeda EC; Rodríguez Y; Monsalve DM; Ramírez-Santana C; Vega DA; Paipilla D; Torres L; Molano-González N; Osorio JE; Anaya JM
    Eur J Neurol; 2018 Apr; 25(4):644-650. PubMed ID: 29266602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A unique case of Miller Fisher-Guillain-Barré overlap syndrome in a liver transplant recipient.
    Ramirez-Sanchez C; Syed R; Meier A; LaBuzetta JN; Hylton DJ; Taremi M
    J Neurovirol; 2021 Oct; 27(5):797-801. PubMed ID: 34550544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination.
    Dang YL; Bryson A
    BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34848426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guillain-Barré syndrome following COVID-19 vaccination: An updated systematic review of cases.
    Shaheen N; Ramadan A; Nashwan AJ; Shaheen A; Ahmad S; Motawea KR; Mohamed S; Mohamed RS; Swed S; Aiash H
    Clin Case Rep; 2023 Jun; 11(6):e7456. PubMed ID: 37305891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Oculopharyngeal Subtype of Guillain-Barré Syndrome Sparing the Trochlear and Abducens Nerves.
    Arakawa M; Yamazaki M; Toda Y; Ozawa A; Kimura K
    Intern Med; 2020 May; 59(9):1215-1217. PubMed ID: 32023583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging infectious diseases, vaccines and Guillain-Barré syndrome.
    Koike H; Katsuno M
    Clin Exp Neuroimmunol; 2021 Aug; 12(3):165-170. PubMed ID: 34230841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guillain-Barré syndrome temporally associated with COVID-19 vaccines in Victoria, Australia.
    Osowicki J; Morgan HJ; Harris A; Clothier HJ; Buttery JP; Kiers L; Crawford NW;
    Vaccine; 2022 Dec; 40(52):7579-7585. PubMed ID: 36357291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case series of parainfectious Guillain-Barré syndrome linked to influenza A (H1N1) virus infection.
    Grisanti SG; Franciotta D; Garnero M; Zuppa A; Massa F; Mobilia EM; Pesce G; Schenone A; Benedetti L
    J Neuroimmunol; 2021 Aug; 357():577605. PubMed ID: 34058509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases.
    Bouattour N; Hdiji O; Sakka S; Fakhfakh E; Moalla K; Daoud S; Farhat N; Damak M; Mhiri C
    Neurol Sci; 2022 Feb; 43(2):755-761. PubMed ID: 34796417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guillain-Barre Syndrome Followed by Covid-19 Infection, Vaccination and Other Precipitating Factors during the Pandemic.
    Martic V; Fejzic E; Danilovic M; Lazarevic S; Rajic S; Roganovic M; Stojanov A; Jovin Z; Debeljevic M; Raicevic R
    Ann Indian Acad Neurol; 2023; 26(3):256-260. PubMed ID: 37538436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 50-Year-Old Patient with Guillain-Barré Syndrome after COVID-19: A Case Report.
    Chmiela T; Rzepka M; Krzystanek E; Gorzkowska A
    Medicina (Kaunas); 2021 Jul; 57(8):. PubMed ID: 34440980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute-onset chronic inflammatory demyelinating polyneuropathy after COVID-19 infection and subsequent ChAdOx1 nCoV-19 vaccination.
    Suri V; Pandey S; Singh J; Jena A
    BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34607818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.